Literature DB >> 1107034

Heterogeneity of lipopolysaccharides. Analysis of polysaccharide chain lengths by sodium dodecylsulfate-polyacrylamide gel electrophoresis.

B Jann, K Reske, K Jann.   

Abstract

Lipopolysaccharide preparations from R(rough) Escherichia coli O8-,SR(semirough) Salmonella typhimurium and S (smooth) strains E. coli O8 and Citrobacter 396 were disintegrated with sodium dodecylsulfate and subjected to polyacrylamide gel electrophoresis in the presence of 1% sodium dodecylsulfate. The results obtained were compared with those obtained from the same lipopolysaccharide preparations by degradation analysis. In dodecylsulfate gel electrophoresis the lipopolysaccharide preparation from the E. coli R mutant and the S. typhimurium SR mutant showed one band each (R-and SR-band, respectively) with different electrophoretic mobilities. The lipopolysaccharide preparations from the E. coli O8-strain exhibited two bands, one of which had the same electrophoretic mobility as the R-band and the other was identified as S-band. The lipopolysaccharide preparation from the Citrobacter 396-S-strain exhibited four bands: one R-band, one SR-band and two S-bands. The results showed that wild-type S strains contain more than one type of lipopolysaccharide. They differ in the length of their O-specific polysaccharide chains. The lipid A content of the different lipopolysaccharide was expressed in their electrophoretic mobilities.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1107034     DOI: 10.1111/j.1432-1033.1975.tb20996.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  81 in total

1.  Biological and physicochemical properties of the lipopolysaccharide of Chromatium vinosum.

Authors:  R E Hurlbert; I M Hurlbert
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

2.  Inhibition of cardiac pacemaker channel hHCN2 depends on intercalation of lipopolysaccharide into channel-containing membrane microdomains.

Authors:  Udo Klöckner; Uwe Rueckschloss; Claudia Grossmann; Saskia Matzat; Katja Schumann; Henning Ebelt; Ursula Müller-Werdan; Harald Loppnow; Karl Werdan; Michael Gekle
Journal:  J Physiol       Date:  2013-12-23       Impact factor: 5.182

3.  Physical properties of short- and long-O-antigen-containing fractions of lipopolysaccharide from Escherichia coli 0111:B4.

Authors:  A A Peterson; A Haug; E J McGroarty
Journal:  J Bacteriol       Date:  1986-01       Impact factor: 3.490

4.  Citrobacter O-antigens: structure of the O-antigenic polysaccharide from Citrobacter sp. 396.

Authors:  B Jann; P Prehm; K Jann
Journal:  J Bacteriol       Date:  1978-05       Impact factor: 3.490

5.  Lipopolysaccharide banding patterns of Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  T R Parr; L E Bryan
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

6.  Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5.

Authors:  S M Burns; S I Hull
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Structural and immunochemical homogeneity of Aeromonas salmonicida lipopolysaccharide.

Authors:  H Chart; D H Shaw; E E Ishiguro; T J Trust
Journal:  J Bacteriol       Date:  1984-04       Impact factor: 3.490

8.  Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis.

Authors:  H Schneider; T L Hale; W D Zollinger; R C Seid; C A Hammack; J M Griffiss
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

9.  The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum.

Authors:  R J Ulevitch; A R Johnston
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

10.  Accelerated adsorption of bacteriophage T5 to Escherichia coli F, resulting from reversible tail fiber-lipopolysaccharide binding.

Authors:  K Heller; V Braun
Journal:  J Bacteriol       Date:  1979-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.